

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.55586013 |
| 2 | regulation of chronic inflammatory response (GO:0002676) | 4.97261019 |
| 3 | regulation of activation of Janus kinase activity (GO:0010533) | 4.88734445 |
| 4 | response to peptidoglycan (GO:0032494) | 4.86812210 |
| 5 | * regulation of T-helper 1 cell differentiation (GO:0045625) | 4.86258422 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78265374 |
| 7 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.71407403 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.70951812 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.68976895 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66184182 |
| 11 | positive regulation of interleukin-12 production (GO:0032735) | 4.63777461 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.54496811 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.52231506 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.48162576 |
| 15 | positive regulation of antigen processing and presentation (GO:0002579) | 4.44856882 |
| 16 | positive regulation of type 2 immune response (GO:0002830) | 4.42023386 |
| 17 | T cell migration (GO:0072678) | 4.39012355 |
| 18 | response to muramyl dipeptide (GO:0032495) | 4.29028951 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.25267144 |
| 20 | * positive regulation of T-helper cell differentiation (GO:0045624) | 4.24713114 |
| 21 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.22344176 |
| 22 | myeloid dendritic cell differentiation (GO:0043011) | 4.13969828 |
| 23 | regulation of memory T cell differentiation (GO:0043380) | 4.12191753 |
| 24 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.11019550 |
| 25 | regulation of antigen processing and presentation (GO:0002577) | 4.06597875 |
| 26 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.02460918 |
| 27 | response to protozoan (GO:0001562) | 3.94289752 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87523378 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87523378 |
| 30 | granulocyte activation (GO:0036230) | 3.86695596 |
| 31 | positive regulation of defense response to virus by host (GO:0002230) | 3.85808777 |
| 32 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.85249192 |
| 33 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.81333900 |
| 34 | neutrophil activation (GO:0042119) | 3.79333051 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76470778 |
| 36 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.74940326 |
| 37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.74316504 |
| 38 | modulation by symbiont of host defense response (GO:0052031) | 3.74316504 |
| 39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.74316504 |
| 40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.74316504 |
| 41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.74316504 |
| 42 | modulation by symbiont of host immune response (GO:0052553) | 3.74316504 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.73560122 |
| 44 | regulation of interleukin-12 production (GO:0032655) | 3.73246287 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.72696362 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.72696362 |
| 47 | cellular response to interferon-beta (GO:0035458) | 3.70225943 |
| 48 | cellular response to exogenous dsRNA (GO:0071360) | 3.69961721 |
| 49 | cellular response to interferon-gamma (GO:0071346) | 3.69797434 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 3.69582755 |
| 51 | response to type I interferon (GO:0034340) | 3.68527785 |
| 52 | negative regulation of interleukin-17 production (GO:0032700) | 3.67918955 |
| 53 | regulation of vitamin metabolic process (GO:0030656) | 3.67231104 |
| 54 | natural killer cell mediated immunity (GO:0002228) | 3.64979915 |
| 55 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.64979915 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.63775772 |
| 57 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.63244515 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.62532333 |
| 59 | * regulation of T-helper cell differentiation (GO:0045622) | 3.61103959 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 3.57677889 |
| 61 | germinal center formation (GO:0002467) | 3.57603969 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.57413521 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.52683141 |
| 64 | T cell lineage commitment (GO:0002360) | 3.49450385 |
| 65 | regulation of interleukin-17 production (GO:0032660) | 3.49152497 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.49133355 |
| 67 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.49060706 |
| 68 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.44167711 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43462205 |
| 70 | dendritic cell differentiation (GO:0097028) | 3.42317908 |
| 71 | negative regulation of interleukin-10 production (GO:0032693) | 3.41462193 |
| 72 | response to interferon-gamma (GO:0034341) | 3.41353307 |
| 73 | negative regulation of viral genome replication (GO:0045071) | 3.37592387 |
| 74 | regulation of immunoglobulin secretion (GO:0051023) | 3.35226444 |
| 75 | regulation of interleukin-10 production (GO:0032653) | 3.34196828 |
| 76 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.32191013 |
| 77 | positive regulation of activated T cell proliferation (GO:0042104) | 3.31163977 |
| 78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.30736109 |
| 79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.30468721 |
| 80 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.29047265 |
| 81 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27418264 |
| 82 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26745203 |
| 83 | response to interferon-beta (GO:0035456) | 3.26510613 |
| 84 | regulation of podosome assembly (GO:0071801) | 3.26432547 |
| 85 | eosinophil chemotaxis (GO:0048245) | 3.25897402 |
| 86 | * regulation of T-helper 1 type immune response (GO:0002825) | 3.25863024 |
| 87 | positive regulation of T cell cytokine production (GO:0002726) | 3.25463888 |
| 88 | * positive regulation of interleukin-2 production (GO:0032743) | 3.24786037 |
| 89 | monocyte chemotaxis (GO:0002548) | 3.24143817 |
| 90 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.23261302 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21036800 |
| 92 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.20817524 |
| 93 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20759288 |
| 94 | positive regulation of interleukin-10 production (GO:0032733) | 3.20123508 |
| 95 | regulation of type 2 immune response (GO:0002828) | 3.20009566 |
| 96 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.19221891 |
| 97 | positive regulation of interferon-beta production (GO:0032728) | 3.18383701 |
| 98 | B cell proliferation (GO:0042100) | 3.17774790 |
| 99 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.17436591 |
| 100 | positive regulation of heat generation (GO:0031652) | 3.14951468 |
| 101 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.14711170 |
| 102 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.12621267 |
| 103 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12060310 |
| 104 | kynurenine metabolic process (GO:0070189) | 3.11493548 |
| 105 | regulation of fever generation (GO:0031620) | 3.10625692 |
| 106 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10134406 |
| 107 | negative regulation of cell killing (GO:0031342) | 3.10134406 |
| 108 | positive regulation of humoral immune response (GO:0002922) | 3.10081584 |
| 109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09408835 |
| 110 | regulation of hypersensitivity (GO:0002883) | 3.09029210 |
| 111 | regulation of mononuclear cell migration (GO:0071675) | 3.08162647 |
| 112 | * regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.08085853 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07743053 |
| 114 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.04044895 |
| 115 | regulation of defense response to virus by host (GO:0050691) | 3.03864571 |
| 116 | regulation of tolerance induction (GO:0002643) | 3.03778724 |
| 117 | respiratory burst (GO:0045730) | 3.03596785 |
| 118 | cytokine secretion (GO:0050663) | 3.03150255 |
| 119 | positive regulation of B cell mediated immunity (GO:0002714) | 3.01215155 |
| 120 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.01215155 |
| 121 | regulation of T cell cytokine production (GO:0002724) | 3.01111554 |
| 122 | B cell receptor signaling pathway (GO:0050853) | 2.99110473 |
| 123 | eosinophil migration (GO:0072677) | 2.98821527 |
| 124 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98502485 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.97873094 |
| 126 | tryptophan catabolic process (GO:0006569) | 2.97873094 |
| 127 | indole-containing compound catabolic process (GO:0042436) | 2.97873094 |
| 128 | negative thymic T cell selection (GO:0045060) | 2.96788818 |
| 129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.95521458 |
| 130 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95409812 |
| 131 | natural killer cell activation involved in immune response (GO:0002323) | 2.94495491 |
| 132 | macrophage activation involved in immune response (GO:0002281) | 2.94172384 |
| 133 | defense response to protozoan (GO:0042832) | 2.93103068 |
| 134 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.92986373 |
| 135 | leukocyte aggregation (GO:0070486) | 2.92680685 |
| 136 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.92176518 |
| 137 | regulation of growth of symbiont in host (GO:0044126) | 2.92176518 |
| 138 | * positive regulation of T-helper 1 type immune response (GO:0002827) | 2.90998288 |
| 139 | T cell activation involved in immune response (GO:0002286) | 2.90298212 |
| 140 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.89469247 |
| 141 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88020782 |
| 142 | response to host immune response (GO:0052572) | 2.88020782 |
| 143 | positive regulation of response to biotic stimulus (GO:0002833) | 2.87822976 |
| 144 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.87407837 |
| 145 | B cell mediated immunity (GO:0019724) | 2.87406792 |
| 146 | natural killer cell activation (GO:0030101) | 2.86419409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.15862989 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.77377289 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.80271862 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.85596660 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.57374104 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.55327630 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.15322889 |
| 8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.78360072 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.67458581 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.61603463 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54455977 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.31780517 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.18820235 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01004563 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00518881 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87483541 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80868311 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68486460 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.60190384 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57514792 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41376024 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.37503128 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15068280 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11722595 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04341696 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92325910 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.91185084 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85973951 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82498462 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73954200 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73783537 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72428153 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.69770418 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67753339 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.62727829 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59846158 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52828436 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.51852559 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51616290 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45749587 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45214693 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40192067 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38050045 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37164357 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26526415 |
| 46 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25038314 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23652970 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20375519 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18660802 |
| 50 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18112400 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17580260 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16868485 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15262849 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13744825 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12778843 |
| 56 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07826637 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05510855 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04887231 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04694527 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00901841 |
| 61 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96349949 |
| 62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96349949 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95420701 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95314639 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93629264 |
| 66 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93488589 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93273725 |
| 68 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92573452 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92314787 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91948896 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90760959 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89473605 |
| 73 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88692673 |
| 74 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88110236 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87706259 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87162637 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86407927 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85651282 |
| 79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85585623 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 0.85238326 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84333250 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84233565 |
| 83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83779137 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83436786 |
| 85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82582614 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81103534 |
| 87 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80683001 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79517396 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79484378 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79403089 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79175313 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79008823 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78650756 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76225754 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76048661 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76048661 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73371162 |
| 98 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73091744 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72316674 |
| 100 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72295503 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72183298 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71821009 |
| 103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71323916 |
| 104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70898056 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70451463 |
| 106 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69249183 |
| 107 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67956049 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67641188 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.67501136 |
| 110 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.64549436 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64276054 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63642506 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.63364840 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.63226969 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62293172 |
| 116 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.60768326 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60557915 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60307275 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60192217 |
| 120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59310981 |
| 121 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58913949 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58853706 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58206613 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58089232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.00277488 |
| 2 | MP0009785_altered_susceptibility_to | 4.02001928 |
| 3 | MP0003436_decreased_susceptibility_to | 3.89332168 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.87129910 |
| 5 | MP0000685_abnormal_immune_system | 3.72459729 |
| 6 | MP0006082_CNS_inflammation | 3.52879836 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.27329550 |
| 8 | MP0001790_abnormal_immune_system | 3.15441518 |
| 9 | MP0005387_immune_system_phenotype | 3.15441518 |
| 10 | MP0005671_abnormal_response_to | 3.13554881 |
| 11 | MP0002254_reproductive_system_inflammat | 2.95383966 |
| 12 | MP0001348_abnormal_lacrimal_gland | 2.92367389 |
| 13 | MP0005025_abnormal_response_to | 2.90546469 |
| 14 | MP0002419_abnormal_innate_immunity | 2.89497220 |
| 15 | MP0003303_peritoneal_inflammation | 2.85381487 |
| 16 | MP0004510_myositis | 2.84812977 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.62459314 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.59319151 |
| 19 | * MP0002723_abnormal_immune_serum | 2.51647057 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.35833630 |
| 21 | MP0003724_increased_susceptibility_to | 2.32951973 |
| 22 | * MP0001819_abnormal_immune_cell | 2.25938838 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.20986458 |
| 24 | MP0002006_tumorigenesis | 2.16314944 |
| 25 | MP0005310_abnormal_salivary_gland | 2.09818156 |
| 26 | MP0005451_abnormal_body_composition | 2.01294332 |
| 27 | MP0001853_heart_inflammation | 1.97195078 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.93438093 |
| 29 | MP0002405_respiratory_system_inflammati | 1.89898018 |
| 30 | MP0009764_decreased_sensitivity_to | 1.87022985 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.84877326 |
| 32 | MP0004947_skin_inflammation | 1.80692984 |
| 33 | MP0001346_abnormal_lacrimal_gland | 1.80527921 |
| 34 | MP0003448_altered_tumor_morphology | 1.78806899 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.75132379 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.73383515 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.71191097 |
| 38 | * MP0000716_abnormal_immune_system | 1.66393336 |
| 39 | MP0002163_abnormal_gland_morphology | 1.59000252 |
| 40 | * MP0002398_abnormal_bone_marrow | 1.58718517 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.58050235 |
| 42 | MP0008469_abnormal_protein_level | 1.50172066 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.47791489 |
| 44 | MP0000858_altered_metastatic_potential | 1.44860228 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.39589142 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.35243877 |
| 47 | MP0009278_abnormal_bone_marrow | 1.33558817 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.32319212 |
| 49 | MP0001873_stomach_inflammation | 1.31672250 |
| 50 | * MP0002429_abnormal_blood_cell | 1.30318187 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.29649941 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.28944221 |
| 53 | MP0000343_altered_response_to | 1.25665694 |
| 54 | MP0003091_abnormal_cell_migration | 1.23105670 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.23052908 |
| 56 | MP0003075_altered_response_to | 1.20988968 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.17960185 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.17960185 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.13295249 |
| 60 | * MP0000689_abnormal_spleen_morphology | 1.12612666 |
| 61 | * MP0002722_abnormal_immune_system | 1.10729460 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.05862506 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.05648805 |
| 64 | MP0002933_joint_inflammation | 0.99407088 |
| 65 | MP0005390_skeleton_phenotype | 0.98926993 |
| 66 | MP0003300_gastrointestinal_ulcer | 0.94335872 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.94125839 |
| 68 | MP0009840_abnormal_foam_cell | 0.93869722 |
| 69 | MP0003828_pulmonary_edema | 0.91517478 |
| 70 | MP0008057_abnormal_DNA_replication | 0.90208579 |
| 71 | MP0003172_abnormal_lysosome_physiology | 0.89848398 |
| 72 | MP0005166_decreased_susceptibility_to | 0.89373664 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 0.89158065 |
| 74 | MP0009763_increased_sensitivity_to | 0.89033342 |
| 75 | MP0002877_abnormal_melanocyte_morpholog | 0.88725329 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.88572344 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.86685819 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.84519185 |
| 79 | MP0010307_abnormal_tumor_latency | 0.82517406 |
| 80 | MP0008874_decreased_physiological_sensi | 0.79044105 |
| 81 | MP0003195_calcinosis | 0.76950032 |
| 82 | MP0005164_abnormal_response_to | 0.76424939 |
| 83 | MP0003806_abnormal_nucleotide_metabolis | 0.75388042 |
| 84 | MP0000604_amyloidosis | 0.74588769 |
| 85 | MP0005023_abnormal_wound_healing | 0.72009882 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.70823851 |
| 87 | MP0000767_abnormal_smooth_muscle | 0.69831919 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.69381345 |
| 89 | MP0000249_abnormal_blood_vessel | 0.68744647 |
| 90 | MP0002009_preneoplasia | 0.68192152 |
| 91 | MP0003690_abnormal_glial_cell | 0.66115890 |
| 92 | MP0001851_eye_inflammation | 0.66097580 |
| 93 | MP0003045_fibrosis | 0.64394841 |
| 94 | MP0005647_abnormal_sex_gland | 0.64128480 |
| 95 | MP0003646_muscle_fatigue | 0.63090794 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.62158406 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.61287038 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.60596865 |
| 99 | MP0000627_abnormal_mammary_gland | 0.60104524 |
| 100 | MP0003705_abnormal_hypodermis_morpholog | 0.59563650 |
| 101 | MP0000609_abnormal_liver_physiology | 0.59522613 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.59455389 |
| 103 | * MP0002693_abnormal_pancreas_physiology | 0.59050332 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.58952652 |
| 105 | MP0005165_increased_susceptibility_to | 0.56936735 |
| 106 | MP0000371_diluted_coat_color | 0.56729912 |
| 107 | MP0001881_abnormal_mammary_gland | 0.55396021 |
| 108 | MP0005535_abnormal_body_temperature | 0.55009412 |
| 109 | MP0008004_abnormal_stomach_pH | 0.54889791 |
| 110 | MP0000490_abnormal_crypts_of | 0.53149616 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.52393062 |
| 112 | MP0000920_abnormal_myelination | 0.51628553 |
| 113 | MP0001663_abnormal_digestive_system | 0.50849021 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.50345655 |
| 115 | MP0003866_abnormal_defecation | 0.49936041 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.49688314 |
| 117 | MP0009115_abnormal_fat_cell | 0.48903697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.54786626 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.49205540 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.00642816 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.28250120 |
| 5 | Optic neuritis (HP:0100653) | 5.28250120 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.27986531 |
| 7 | Myositis (HP:0100614) | 5.15459580 |
| 8 | Orchitis (HP:0100796) | 5.08211474 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 5.02736406 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.96128347 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.83772439 |
| 12 | Increased IgM level (HP:0003496) | 4.80305941 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.53810618 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.49723293 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.16058303 |
| 16 | Recurrent skin infections (HP:0001581) | 4.14215658 |
| 17 | Vasculitis (HP:0002633) | 4.02143564 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90456228 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90456228 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90456228 |
| 21 | Stomatitis (HP:0010280) | 3.90026289 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81204330 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81204330 |
| 24 | Recurrent viral infections (HP:0004429) | 3.70830674 |
| 25 | Chronic otitis media (HP:0000389) | 3.70535299 |
| 26 | Basal ganglia calcification (HP:0002135) | 3.68106830 |
| 27 | Gingivitis (HP:0000230) | 3.66181780 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 3.55377811 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.49605442 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.47319422 |
| 31 | Lymphopenia (HP:0001888) | 3.39486475 |
| 32 | Obstructive lung disease (HP:0006536) | 3.34625531 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34625531 |
| 34 | Recurrent sinusitis (HP:0011108) | 3.31313551 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 3.30576937 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.26070952 |
| 37 | Arterial thrombosis (HP:0004420) | 3.22048327 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.21921969 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 3.15242790 |
| 40 | Periodontitis (HP:0000704) | 3.13751865 |
| 41 | Hypertensive crisis (HP:0100735) | 2.99059610 |
| 42 | Restrictive lung disease (HP:0002091) | 2.96261686 |
| 43 | Nasal polyposis (HP:0100582) | 2.87553476 |
| 44 | Tetraparesis (HP:0002273) | 2.87255497 |
| 45 | Cellulitis (HP:0100658) | 2.83673828 |
| 46 | Meningitis (HP:0001287) | 2.82937122 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82209596 |
| 48 | B lymphocytopenia (HP:0010976) | 2.80170618 |
| 49 | Leukocytosis (HP:0001974) | 2.78064024 |
| 50 | IgM deficiency (HP:0002850) | 2.74920336 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.74913220 |
| 52 | Amaurosis fugax (HP:0100576) | 2.73090275 |
| 53 | Eosinophilia (HP:0001880) | 2.70181027 |
| 54 | Loss of speech (HP:0002371) | 2.69490164 |
| 55 | Hemoptysis (HP:0002105) | 2.68875650 |
| 56 | Urticaria (HP:0001025) | 2.68731540 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.64882443 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.64032188 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.64032188 |
| 60 | Peritonitis (HP:0002586) | 2.61590078 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.57920990 |
| 62 | Myocardial infarction (HP:0001658) | 2.54281181 |
| 63 | Porencephaly (HP:0002132) | 2.53582020 |
| 64 | Abnormality of T cell number (HP:0011839) | 2.52738512 |
| 65 | Pustule (HP:0200039) | 2.51499617 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.51364217 |
| 67 | Axonal loss (HP:0003447) | 2.49738123 |
| 68 | Gingival bleeding (HP:0000225) | 2.49375650 |
| 69 | Dysostosis multiplex (HP:0000943) | 2.47705539 |
| 70 | Joint swelling (HP:0001386) | 2.39703075 |
| 71 | Thick nail (HP:0001805) | 2.39534060 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.38308113 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.37299834 |
| 74 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37136973 |
| 75 | Encephalitis (HP:0002383) | 2.35846192 |
| 76 | Abnormality of the endocardium (HP:0004306) | 2.33325608 |
| 77 | Abnormality of the pericardium (HP:0001697) | 2.32575509 |
| 78 | Prostate neoplasm (HP:0100787) | 2.30890495 |
| 79 | Recurrent bronchitis (HP:0002837) | 2.30642513 |
| 80 | Lymphoma (HP:0002665) | 2.30631919 |
| 81 | Colitis (HP:0002583) | 2.30270646 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29836683 |
| 83 | Osteomyelitis (HP:0002754) | 2.26276162 |
| 84 | Granulocytopenia (HP:0001913) | 2.26266565 |
| 85 | Increased IgE level (HP:0003212) | 2.24850865 |
| 86 | Anorexia (HP:0002039) | 2.23933810 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.23763481 |
| 88 | Hematochezia (HP:0002573) | 2.23306237 |
| 89 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21259058 |
| 90 | Inflammation of the large intestine (HP:0002037) | 2.19985390 |
| 91 | Polyneuropathy (HP:0001271) | 2.19898731 |
| 92 | Increased serum ferritin (HP:0003281) | 2.15892042 |
| 93 | IgA deficiency (HP:0002720) | 2.13885696 |
| 94 | Fatigue (HP:0012378) | 2.09890612 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.09656481 |
| 96 | Arthralgia (HP:0002829) | 2.09616943 |
| 97 | Xerostomia (HP:0000217) | 2.09441198 |
| 98 | Poor head control (HP:0002421) | 2.08994688 |
| 99 | Gangrene (HP:0100758) | 2.07250519 |
| 100 | Thoracolumbar scoliosis (HP:0002944) | 2.07219810 |
| 101 | Petechiae (HP:0000967) | 2.04971480 |
| 102 | Skin ulcer (HP:0200042) | 2.04510043 |
| 103 | Abnormality of the prostate (HP:0008775) | 2.02654230 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.02269246 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.01834879 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.00428112 |
| 107 | Leukopenia (HP:0001882) | 2.00407610 |
| 108 | Emphysema (HP:0002097) | 2.00100424 |
| 109 | Abnormality of the pleura (HP:0002103) | 1.99894262 |
| 110 | Hydroxyprolinuria (HP:0003080) | 1.99822747 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 1.99822747 |
| 112 | Abnormality of T cells (HP:0002843) | 1.98935605 |
| 113 | Memory impairment (HP:0002354) | 1.96851589 |
| 114 | Parakeratosis (HP:0001036) | 1.95901155 |
| 115 | Pulmonary embolism (HP:0002204) | 1.95563992 |
| 116 | T lymphocytopenia (HP:0005403) | 1.93821892 |
| 117 | Skin rash (HP:0000988) | 1.93271092 |
| 118 | Chronic sinusitis (HP:0011109) | 1.92645397 |
| 119 | Disinhibition (HP:0000734) | 1.89689585 |
| 120 | IgG deficiency (HP:0004315) | 1.89320638 |
| 121 | Chest pain (HP:0100749) | 1.87473247 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.86680728 |
| 123 | Panhypogammaglobulinemia (HP:0003139) | 1.86680053 |
| 124 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84100420 |
| 125 | Keratitis (HP:0000491) | 1.83451012 |
| 126 | Progressive visual loss (HP:0000529) | 1.80408570 |
| 127 | Chronic diarrhea (HP:0002028) | 1.79057937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 6.19578860 |
| 2 | TBK1 | 3.92802669 |
| 3 | IKBKB | 3.56805731 |
| 4 | TYK2 | 3.56638865 |
| 5 | PRPF4B | 3.37225916 |
| 6 | JAK3 | 3.36713425 |
| 7 | BLK | 2.92580714 |
| 8 | IRAK4 | 2.90805288 |
| 9 | IKBKE | 2.74715315 |
| 10 | MAP3K13 | 2.71587930 |
| 11 | RIPK4 | 2.61496677 |
| 12 | IRAK3 | 2.54403462 |
| 13 | CHUK | 2.47192949 |
| 14 | MAP4K1 | 2.44969618 |
| 15 | JAK1 | 2.40363214 |
| 16 | TXK | 2.10387825 |
| 17 | EPHB1 | 1.95472018 |
| 18 | PIM2 | 1.94306863 |
| 19 | TAOK2 | 1.88499714 |
| 20 | KIT | 1.65881357 |
| 21 | CDC42BPA | 1.47610628 |
| 22 | CSK | 1.46968994 |
| 23 | BMPR2 | 1.43698319 |
| 24 | SYK | 1.41870772 |
| 25 | BMX | 1.40626846 |
| 26 | CSF1R | 1.40016012 |
| 27 | PBK | 1.36353284 |
| 28 | FGR | 1.32346988 |
| 29 | PIM1 | 1.30886913 |
| 30 | EPHA3 | 1.29066884 |
| 31 | EIF2AK2 | 1.27713762 |
| 32 | TRPM7 | 1.23791888 |
| 33 | FGFR4 | 1.21340293 |
| 34 | EIF2AK3 | 1.19524503 |
| 35 | BTK | 1.18624088 |
| 36 | HCK | 1.18118221 |
| 37 | ZAP70 | 1.12855804 |
| 38 | ERN1 | 1.09729496 |
| 39 | JAK2 | 1.08392581 |
| 40 | NEK9 | 1.05227488 |
| 41 | MST4 | 1.04541097 |
| 42 | LCK | 1.03824986 |
| 43 | STK24 | 1.02225458 |
| 44 | FGFR3 | 1.00355020 |
| 45 | STK10 | 0.96369402 |
| 46 | PTK6 | 0.95530519 |
| 47 | CDK12 | 0.91947401 |
| 48 | TEC | 0.87467371 |
| 49 | LYN | 0.87046705 |
| 50 | MOS | 0.87015838 |
| 51 | TESK1 | 0.83604102 |
| 52 | ABL2 | 0.83206674 |
| 53 | TYRO3 | 0.81457516 |
| 54 | MAPK11 | 0.81440004 |
| 55 | TTN | 0.78558574 |
| 56 | RPS6KA4 | 0.75767425 |
| 57 | PRKCD | 0.74371116 |
| 58 | STK4 | 0.71172244 |
| 59 | ITK | 0.70457320 |
| 60 | IRAK2 | 0.69169251 |
| 61 | MATK | 0.67978407 |
| 62 | LRRK2 | 0.67189640 |
| 63 | MAPKAPK2 | 0.66636097 |
| 64 | ABL1 | 0.66284459 |
| 65 | FES | 0.64957253 |
| 66 | SMG1 | 0.64675723 |
| 67 | IRAK1 | 0.63501488 |
| 68 | PRKCQ | 0.62660923 |
| 69 | ADRBK2 | 0.62204184 |
| 70 | CCNB1 | 0.62061778 |
| 71 | ERBB3 | 0.61915932 |
| 72 | PKN1 | 0.61907562 |
| 73 | TLK1 | 0.61701163 |
| 74 | STK3 | 0.61233411 |
| 75 | MAP3K11 | 0.60651773 |
| 76 | NUAK1 | 0.60086605 |
| 77 | MAP3K10 | 0.58206276 |
| 78 | EGFR | 0.55837114 |
| 79 | HIPK2 | 0.54547631 |
| 80 | CDK4 | 0.54514999 |
| 81 | MELK | 0.52988121 |
| 82 | MARK3 | 0.52510919 |
| 83 | MAPK4 | 0.51842636 |
| 84 | FLT3 | 0.50778774 |
| 85 | YES1 | 0.50589375 |
| 86 | MAP3K1 | 0.49774393 |
| 87 | TGFBR2 | 0.49711095 |
| 88 | MAP3K9 | 0.49020055 |
| 89 | PDK1 | 0.48299567 |
| 90 | GRK7 | 0.46599209 |
| 91 | ACVR1B | 0.46590454 |
| 92 | TAOK3 | 0.44738927 |
| 93 | SIK3 | 0.43589027 |
| 94 | MAP3K5 | 0.41826279 |
| 95 | GRK6 | 0.40152556 |
| 96 | DMPK | 0.40100893 |
| 97 | CDK6 | 0.39465208 |
| 98 | TAOK1 | 0.39464423 |
| 99 | NLK | 0.37938845 |
| 100 | BCR | 0.36817088 |
| 101 | MAPK7 | 0.36444673 |
| 102 | ARAF | 0.36421435 |
| 103 | RPS6KA1 | 0.36292947 |
| 104 | MAP3K8 | 0.34000744 |
| 105 | INSR | 0.33772000 |
| 106 | NME2 | 0.31246989 |
| 107 | DAPK2 | 0.29738124 |
| 108 | DAPK3 | 0.28260035 |
| 109 | RPS6KA5 | 0.26997993 |
| 110 | RIPK1 | 0.26317406 |
| 111 | ALK | 0.26107011 |
| 112 | SIK2 | 0.25199226 |
| 113 | SCYL2 | 0.24789036 |
| 114 | MAPKAPK5 | 0.24501606 |
| 115 | DYRK1B | 0.24105441 |
| 116 | PDPK1 | 0.23554634 |
| 117 | MAP2K3 | 0.22103162 |
| 118 | MAP3K3 | 0.20315570 |
| 119 | DDR2 | 0.19070489 |
| 120 | SRC | 0.18371548 |
| 121 | GSK3A | 0.18017154 |
| 122 | PAK4 | 0.17992044 |
| 123 | EEF2K | 0.17961232 |
| 124 | MAPK3 | 0.17043047 |
| 125 | PRKAA2 | 0.16896510 |
| 126 | BMPR1B | 0.16560389 |
| 127 | SGK1 | 0.16490057 |
| 128 | IGF1R | 0.16324964 |
| 129 | CLK1 | 0.15557342 |
| 130 | MAP2K6 | 0.15517140 |
| 131 | PASK | 0.14990980 |
| 132 | PDGFRA | 0.14678614 |
| 133 | AKT1 | 0.14447270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.44364288 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22254954 |
| 3 | * Allograft rejection_Homo sapiens_hsa05330 | 3.20229814 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.06694457 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.74848338 |
| 6 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.72330163 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55664424 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.55429988 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.44012463 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.36610017 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36591850 |
| 12 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36547672 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20211869 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.17637534 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.17180232 |
| 16 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.14227315 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12654969 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.08584969 |
| 19 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06550561 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 2.04727766 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.82066551 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.80752641 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.79545539 |
| 24 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73639766 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71831450 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.70861945 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70372455 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.67311890 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60774469 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58796842 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.56687045 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49912522 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.48213465 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.47680783 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46379297 |
| 36 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.45917198 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45902850 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39588917 |
| 39 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.35341205 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.28707255 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.27956356 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.22621769 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.20524152 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07770274 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07116270 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 1.03213769 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02153527 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99647319 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.98661864 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.89371782 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88014992 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84037865 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82280070 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79150558 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76808390 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74909635 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73724232 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72698708 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69566934 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67249698 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64723380 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.64461107 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60957676 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60712258 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56836616 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53725444 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48110351 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46641771 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46101875 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.44743415 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44438551 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44322391 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.44079855 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43738984 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42837052 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38188797 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37781442 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37106082 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35607378 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35319612 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33104104 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29972337 |
| 83 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29514318 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28021989 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26894799 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26108650 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25200715 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22758829 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.21313577 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21065345 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20519814 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20475060 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.20226536 |
| 94 | Adherens junction_Homo sapiens_hsa04520 | 0.20218114 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17493281 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.17157377 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16719322 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.14806497 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12911046 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.11990962 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.10964077 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07012222 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.03742972 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.03461878 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.03309673 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.03307929 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.02955337 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.02484673 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02478285 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01388278 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00918422 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0612302 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0492953 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0066798 |

